Glucose-Responsive Microneedle Patches for Diabetes Treatment

Journal of Diabetes Science and Technology
Guojun ChenZhen Gu

Abstract

Antidiabetic therapeutics, including insulin as well as glucagon-like peptide 1 (GLP-1) and its analogs, are essential for people with diabetes to regulate their blood glucose levels. Nevertheless, conventional treatments based on hypodermic administration is commonly associated with poor blood glucose control, a lack of patient compliance, and a high risk of hypoglycemia. Closed-loop drug delivery strategies, also known as self-regulated administration, which can intelligently govern the drug release kinetics in response to the fluctuation in blood glucose levels, show tremendous promise in diabetes therapy. In the meantime, the advances in the development and use of microneedle (MN)-array patches for transdermal drug delivery offer an alternative method to conventional hypodermic administration. Hence, glucose-responsive MN-array patches for the treatment of diabetes have attracted increasing attentions in recent years. This review summarizes recent advances in glucose-responsive MN-array patch systems. Their opportunities and challenges for clinical translation are also discussed.

References

Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·F Fischel-GhodsianR Langer
Apr 1, 1997·Diabetic Medicine : a Journal of the British Diabetic Association·A Zambanini, M D Feher
Apr 25, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·K PodualN A Peppas
Sep 12, 2001·Lancet·D R OwensG B Bolli
Jan 31, 2002·Annual Review of Medicine·Helaine E Resnick, Barbara V Howard
Jan 28, 2004·Cellular and Molecular Life Sciences : CMLS·P ChelikaniP C Loewen
Mar 17, 2004·Advanced Drug Delivery Reviews·Mark R Prausnitz
May 13, 2005·IEEE Transactions on Bio-medical Engineering·Shawn P DavisMark R Prausnitz
Feb 14, 2006·Current Drug Delivery·Sion A CoulmanJames C Birchall
Apr 21, 2009·Biotechnology Advances·Sandip B BankarLaxmi Ananthanarayan
Nov 10, 2009·Diabetes Research and Clinical Practice·J E ShawP Z Zimmet
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association
Jun 12, 2012·Lancet·Adam G TabákMika Kivimäki
Nov 28, 2012·Advanced Healthcare Materials·Kaitlin M BratlieDaniel G Anderson
May 4, 2013·ACS Nano·Zhen GuDaniel G Anderson
Apr 18, 2014·Journal of Education and Health Promotion·Mohammad Asif
Nov 29, 2014·Nature Reviews. Drug Discovery·Omid VeisehRobert Langer
Feb 3, 2015·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Rocco Michael DiSantoZhen Gu
Jun 24, 2015·Proceedings of the National Academy of Sciences of the United States of America·Jicheng YuZhen Gu
Aug 8, 2015·Nature·Omid Veiseh, Robert Langer
Oct 11, 2015·Journal of Drug Targeting·Matthew J Webber, Daniel G Anderson
Jul 29, 2016·Diabetes Care·Silvio E InzucchiUNKNOWN IRIS Trial Investigators
Nov 26, 2016·Advanced Materials·Yuqi ZhangZhen Gu
Mar 16, 2017·Current Opinion in Biotechnology·Jicheng YuZhen Gu
Nov 12, 2017·Science Immunology·Yanqi YeZhen Gu
Sep 1, 2016·Bioengineering & Translational Medicine·Jicheng YuZhen Gu
Dec 5, 2017·Science Advances·Akira MatsumotoTakayoshi Suganami

❮ Previous
Next ❯

Citations

Aug 3, 2018·Journal of Diabetes Science and Technology·Barry H Ginsberg
Nov 24, 2018·Journal of Diabetes Science and Technology·Bithika Thompson, Curtiss B Cook
Aug 20, 2019·Advanced Materials·Jinqiang WangZhen Gu
Oct 1, 2019·American Journal of Therapeutics·Simona Cernea, Itamar Raz
Nov 7, 2019·Current Drug Delivery·Sunil Kumar DubeyShailendra Saraf
Apr 21, 2020·Diabetes Technology & Therapeutics·Leah M Wilson, Jessica R Castle
Aug 12, 2020·Biomaterials Science·Xingyu Chen, Dongqiong Yang
Jan 4, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Suman PahalPraveen Kumar Vemula
Jul 7, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Minglong ChenChuanbin Wu
Dec 29, 2020·Chemical Reviews·Stephanie FuchsMinglin Ma
Jun 11, 2021·Advanced Drug Delivery Reviews·Emma McAlisterRyan F Donnelly
Jun 6, 2021·Biosensors & Bioelectronics·Nur Farrahain Nadia AhmadYew Hoong Wong
Aug 28, 2021·Advanced Healthcare Materials·Li ZhaoRyan F Donnelly
Nov 10, 2021·ACS Applied Materials & Interfaces·Rosita PrimaveraPaolo Decuzzi
Dec 11, 2021·Journal of Diabetes Science and Technology·Lutz HeinemannJulia K Mader

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Related Papers

Current Opinion in Biotechnology
Jicheng YuZhen Gu
International Journal of Pharmaceutics
Jicheng YuZhen Gu
The International Journal of Artificial Organs
P BrunettiG P Reboldi
© 2022 Meta ULC. All rights reserved